| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Boston Scientific Corp (BSX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. BSX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 168.0K | $7.45M | - | |
| CFO | 35.8K | $1.59M | - | |
| VP | 35.4K | $1.57M | - | |
| VP | 30.6K | $1.35M | - | |
| Dir | 24.1K | $1.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Carruthers Wendy | EVP, Human Resources | Sale+OE | 6,983 | $66.35 | $463,322.05 | -11.5% | +11.7% | +54.6% | |
| Feb 26, 2024 | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sale+OE | 9,335 | $67.07 | $626,098.45 | -24.4% | +12.7% | +51.1% | |
| Feb 23, 2024 | Carruthers Wendy | EVP, Human Resources | Sale+OE | 6,983 | $66.89 | $467,092.87 | -11.0% | +11.0% | +56.0% | |
| Feb 21, 2024 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 4,960 | $66.35 | $329,096.00 | -6.4% | +15.1% | +60.2% | |
| Feb 20, 2024 | Brennan Daniel J.47 | EVP And CFO | Sale+OE | 13,662 | $65.86 | $899,779.32 | -4.8% | +13.8% | +59.6% | |
| Feb 13, 2024 | Ludwig Edward J60 | Director | Sale+OE | 7,000 | $65.03 | $455,223.30 | -14.5% | +12.1% | +62.8% | |
| Jan 12, 2024 | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 11,660 | $60.00 | $699,600.00 | -6.3% | +14.8% | +58.3% | |
| Jan 9, 2024 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 15,172 | $59.25 | $898,941.00 | -21.1% | +16.0% | +62.0% | |
| Jan 4, 2024 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sale+OE | 15,000 | $58.40 | $876,001.50 | -21.0% | +17.1% | +55.9% | |
| Jan 3, 2024 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 11,931 | $57.82 | $689,862.35 | -17.4% | +17.1% | +55.2% |